​

Cullinan Therapeutics Ownership | Who Owns Cullinan Therapeutics?

OverviewForecastFinancialsChart

Cullinan Therapeutics Ownership Summary

Cullinan Therapeutics is owned by 41.16% institutional investors, 0.64% insiders, and 58.21% retail investors. Lynx1 capital management lp is the largest institutional shareholder, holding 15.14% of CGEM shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.07% of its assets in Cullinan Therapeutics shares.

CGEM Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCullinan Therapeutics41.16%0.64%58.21%
SectorHealthcare Stocks 232.86%10.65%-143.51%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Lynx1 capital management lp8.96M15.14%$127.37M
Bioimpact capital7.65M12.96%$45.35M
Bvf inc/il5.75M9.74%$34.10M
Blackrock3.55M8.25%$61.92M
Blackrock funding, inc. /de4.40M7.46%$45.54M
Vanguard group3.30M5.59%$34.14M
Deerfield management company, l.p. (series c)2.93M4.96%$17.36M
Blue owl capital lp2.35M3.98%$24.33M
Kynam capital management, lp2.30M3.90%$13.65M
Orbimed advisors1.92M3.26%$11.41M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lynx1 capital management lp8.96M20.13%$127.37M
Bioimpact capital7.65M7.42%$45.35M
Nextech invest1.14M2.25%$13.90M
Blue owl capital lp2.35M1.82%$24.33M
Bvf inc/il5.75M1.38%$34.10M
Nextech invest1.14M1.03%$6.77M
Kynam capital management, lp2.30M1.02%$13.65M
Boxer capital657.89K0.60%$11.47M
Artal group1.06M0.47%$18.45M
Vr adviser1.38M0.46%$8.18M

Top Buyers

HolderShares% AssetsChange
Blackrock3.55M0.00%1.12M
Artal group1.06M0.47%1.06M
Boxer capital657.89K0.60%657.89K
Morgan stanley766.93K0.00%366.78K
Vanguard group3.30M0.00%355.18K

Top Sellers

HolderShares% AssetsChange
Paradigm biocapital advisors lp---2.32M
Holocene advisors, lp---1.53M
Franklin resources---1.42M
Cormorant asset management, lp---1.13M
Adage capital partners gp---1.03M

New Positions

HolderShares% AssetsChangeValue
Artal group1.06M0.47%1.06M$18.45M
Boxer capital657.89K0.60%657.89K$11.47M
Vanguard fiduciary trust342.85K0.00%342.85K$4.87M
Cubist systematic strategies222.32K0.01%222.32K$1.32M
Jump financial194.51K0.01%194.51K$1.15M

Sold Out

HolderChange
Clearstead advisors-4.00
Nelson, van denburg & campbell wealth management group-5.00
Capital performance advisors llp-13.00
Versant capital management-23.00
Corecap advisors-29.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202587-40.00%24,287,663-60.24%410.38%54-36.47%24-33.33%
Sep 30, 20251412.92%61,105,4933.70%1031.04%8120.90%35-14.63%
Jun 30, 2025144-4.00%62,598,313-3.20%1060.88%691.47%44-16.98%
Mar 31, 202519-87.25%31,573,885-51.85%530.43%6-92.68%5-86.11%
Dec 31, 202478-45.07%19,633,373-69.80%330.27%44-48.24%22-21.43%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.86M3.07%-
Vanguard US Total Market Shares ETF1.50M2.57%-
State Street® SPDR® S&P® Biotech ETF1.42M2.31%-14.40K
iShares Russell 2000 ETF1.26M2.06%10.67K
Franklin Small Cap Growth SMA849.95K1.44%849.91K
Franklin US Small Cap Growth Equity849.95K1.44%64.90K
Franklin Biotechnology Discv A(acc)USD842.14K1.43%-
Franklin Small Cap Growth Adv785.04K1.33%-
AB Small Cap Growth A750.85K1.27%-21.14K
Vanguard Institutional Extnd Mkt Idx Tr570.18K0.94%5.32K

Recent Insider Transactions

DateNameRoleActivityValue
May 05, 2026Michaelson Jennifer Chief Scientific OfficerSell$3.12K
May 05, 2026Michaelson Jennifer Chief Scientific OfficerSell$113.88K
Mar 05, 2026Michaelson Jennifer Chief Scientific OfficerSell$125.44K
Feb 25, 2026Michaelson Jennifer Chief Scientific OfficerSell$25.17K
Feb 24, 2026Michaelson Jennifer Chief Scientific OfficerSell$52.11K

Insider Transactions Trends

DateBuySell
2026 Q2-2
2026 Q1-15
2025 Q488
2025 Q3--
2025 Q2--

CGEM Ownership FAQ

Who owns the most shares of Cullinan Therapeutics?

Cullinan Therapeutics’s largest shareholders are Lynx1 capital management lp (8.96M shares, 15.14%), Bioimpact capital (7.65M shares, 12.96%), and Bvf inc/il (5.75M shares, 9.74%). Together, they hold 37.85% of Cullinan Therapeutics’s total shares outstanding.

Does Blackrock own Cullinan Therapeutics?

Yes, BlackRock owns 8.25% of Cullinan Therapeutics, totaling 3.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 61.92M$. In the last quarter, BlackRock increased its holdings by 1.12M shares, a 46.16% change.

Who is Cullinan Therapeutics’s biggest shareholder by percentage of total assets invested?

Lynx1 capital management lp is Cullinan Therapeutics’s biggest shareholder by percentage of total assets invested, with 20.13% of its assets in 8.96M Cullinan Therapeutics shares, valued at 127.37M$.

Who is the top mutual fund holder of Cullinan Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cullinan Therapeutics shares, with 3.07% of its total shares outstanding invested in 1.86M Cullinan Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools